Abstract
Because hepatitis A infection may be more severe in patients with chronic liver disease, we vaccinated 33 children who were chronic HBsAg carriers against hepatitis A virus. Anti-hepatitis A virus seroconversion rates after the first, second, and third doses were 90.9%, 96.9%, and 100%, respectively.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Carrier State
-
Child
-
Child, Preschool
-
Female
-
Hepatitis A / immunology
-
Hepatitis A / prevention & control*
-
Hepatitis A Vaccines
-
Hepatitis B Surface Antigens / analysis*
-
Hepatitis B virus / immunology*
-
Hepatitis B, Chronic / immunology*
-
Humans
-
Male
-
Vaccination
-
Viral Hepatitis Vaccines / administration & dosage*
-
Viral Hepatitis Vaccines / immunology
Substances
-
Hepatitis A Vaccines
-
Hepatitis B Surface Antigens
-
Viral Hepatitis Vaccines